1
|
The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss.
|
Genes Dev
|
2008
|
3.17
|
2
|
Chemopreventive effects of deguelin, a novel Akt inhibitor, on tobacco-induced lung tumorigenesis.
|
J Natl Cancer Inst
|
2005
|
2.09
|
3
|
Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development.
|
Proc Natl Acad Sci U S A
|
2006
|
1.82
|
4
|
Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
|
J Natl Cancer Inst
|
2007
|
1.79
|
5
|
Haploinsufficiency of Mdm2 and Mdm4 in tumorigenesis and development.
|
Mol Cell Biol
|
2007
|
1.64
|
6
|
Impaired angiogenesis in aminopeptidase N-null mice.
|
Proc Natl Acad Sci U S A
|
2007
|
1.53
|
7
|
Ethiodized oil-ethanol capillary embolization in rabbit kidneys: temporal histopathologic findings.
|
Radiology
|
2004
|
1.52
|
8
|
Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
|
Cancer Res
|
2007
|
1.32
|
9
|
Spontaneous tumorigenesis in mice overexpressing the p53-negative regulator Mdm4.
|
Cancer Res
|
2010
|
1.23
|
10
|
Loss of Mdm4 results in p53-dependent dilated cardiomyopathy.
|
Circulation
|
2007
|
1.21
|
11
|
Knockout of the tumor suppressor gene Gprc5a in mice leads to NF-kappaB activation in airway epithelium and promotes lung inflammation and tumorigenesis.
|
Cancer Prev Res (Phila)
|
2010
|
1.11
|
12
|
Transitional cell hyperplasia and carcinomas in urinary bladders of transgenic mice with keratin 5 promoter-driven cyclooxygenase-2 overexpression.
|
Cancer Res
|
2005
|
1.03
|
13
|
Cdk2 is required for breast cancer mediated by the low-molecular-weight isoform of cyclin E.
|
Cancer Res
|
2011
|
1.01
|
14
|
Photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres: A platform for near-infrared light-trigged drug release.
|
J Control Release
|
2011
|
1.00
|
15
|
Hepatic arterial embolization with doxorubicin-loaded superabsorbent polymer microspheres in a rabbit liver tumor model.
|
Cardiovasc Intervent Radiol
|
2011
|
0.91
|
16
|
The antimelanoma immunocytokine scFvMEL/TNF shows reduced toxicity and potent antitumor activity against human tumor xenografts.
|
Neoplasia
|
2006
|
0.89
|
17
|
A biodistribution and toxicity study of cobalt dichloride-N-acetyl cysteine in an implantable MRI marker for prostate cancer treatment.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.85
|
18
|
Differential impacts of insulin-like growth factor-binding protein-3 (IGFBP-3) in epithelial IGF-induced lung cancer development.
|
Endocrinology
|
2011
|
0.82
|
19
|
Inhibition of prostate cancer-meditated osteoblastic bone lesions by the low-calcemic analog 1alpha-hydroxymethyl-16-ene-26,27-bishomo-25-hydroxy vitamin D3.
|
J Steroid Biochem Mol Biol
|
2005
|
0.79
|
20
|
Evaluation of targeted arterial delivery of the branched chain fatty acid 12-methyltetradecanoic acid as a novel therapy for solid tumors.
|
J Exp Ther Oncol
|
2005
|
0.78
|
21
|
Transcatheter arterial embolization of renal VX-2 carcinoma: ethiodol-ethanol capillary embolization combined with carboplatin.
|
Korean J Radiol
|
2007
|
0.77
|
22
|
Vascular injury caused by mechanical thrombectomy in porcine arteries: AKónya eliminator device versus Arrow-Trerotola percutaneous thrombolytic device.
|
J Vasc Interv Radiol
|
2006
|
0.75
|